US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 56.680
  • -0.420-0.74%
Close Jan 8 16:00 ET
  • 56.000
  • -0.680-1.20%
Post 19:59 ET
10.49BMarket Cap-48.86P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Exact Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 699.621M--
--2024/Q4-- / 694.762M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 699.621M--
--2024/Q4-- / 694.762M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--

Unlock Free Earnings Estimates

Exact Sciences Earnings Reports

  • Exact Sciences | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 17:12 ET

  • Exact Sciences | 10-Q: Q2 2024 Earnings Report

    Jul 31, 2024 17:11 ET

  • Exact Sciences | 10-Q: Q1 2024 Earnings Report

    May 8, 2024 17:07 ET

  • Exact Sciences | 10-K: FY2023 Annual Report

    Feb 21, 2024 17:12 ET

    • Read more

    Trending US Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Toll Brothers
    TOL
    +2.56%
    Meritage Homes
    MTH
    +2.34%
    Taylor Morrison Home
    TMHC
    +1.58%
    D.R. Horton
    DHI
    +1.49%
    KB Home
    KBH
    +1.35%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday-0.60%